SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001728117-23-000040
Filing Date
2023-04-28
Accepted
2023-04-28 16:01:53
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A goss-20230427.htm   iXBRL DEF 14A 666259
6 GRAPHIC goss-20230427_g1.jpg GRAPHIC 150783
7 GRAPHIC goss-20230427_g2.jpg GRAPHIC 253512
8 GRAPHIC goss-20230427_g3.jpg GRAPHIC 288986
9 GRAPHIC goss-20230427_g4.jpg GRAPHIC 185553
10 GRAPHIC goss-20230427_g5.jpg GRAPHIC 172934
  Complete submission text file 0001728117-23-000040.txt   3782236

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20230427.xsd EX-101.SCH 6223
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT goss-20230427_def.xml EX-101.DEF 6156
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20230427_lab.xml EX-101.LAB 15076
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20230427_pre.xml EX-101.PRE 9064
13 EXTRACTED XBRL INSTANCE DOCUMENT goss-20230427_htm.xml XML 123388
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38796 | Film No.: 23865732
SIC: 2834 Pharmaceutical Preparations